US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aardvark Therapeutics

5.13

+0.12002.40%

Pre-market: 5.05-0.0831-1.62%06:28 EDT

Volume:276.57K

Turnover:1.43M

Market Cap:111.31M

PE:-1.60

High:5.54

Open:5.11

Low:4.98

Close:5.01

52wk High:17.94

52wk Low:3.35

Shares:21.70M

Float Shares:11.17M

Volume Ratio:1.66

T/O Rate:2.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2080

EPS(LYR):-0.7400

ROE:-66.02%

ROA:-40.38%

PB:1.49

PE(LYR):-6.93

Loading ...

Overview Company News Filings

Press Release: Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

Aardvark Therapeutics, Inc. Expected to Post a Loss of 87 Cents a Share - Earnings Preview

Aardvark Therapeutics Price Target Announced at $6.00/share by HC Wainwright & Co.

Aardvark Therapeutics Announces Annual Shareholder Meeting

Aardvark Therapeutics Implements Executive Retention Bonus Agreements

Aardvark Therapeutics offers CFO Nelson Sun USD 346,500 retention bonus package

FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4

Aardvark Therapeutics downgraded to Underperform from Buy at BofA

Top Midday Decliners

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Aardvark Therapeutics Cut to Neutral From Buy by BTIG

Aardvark Therapeutics Inc trading resumes

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM

Aardvark Therapeutics downgraded to Neutral from Buy at BTIG

Aardvark Therapeutics Could Regain Investor Interest With Upcoming Results -- Market Talk

Aardvark Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS

Morgan Stanley Downgrades Aardvark Therapeutics to Underweight From Equalweight, Cuts Price Target to $3 From $7

MT Newswires Live

Stocks to Watch: Figma, Aardvark, Gambling.com, P3 Health

Aardvark Therapeutics announces FDA clinical hold on ARD-101

Aardvark Therapeutics Says FDA Placed Hold on ARD-101 Trials

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/AARD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":5.13,"timestamp":1789156800000,"preClose":5.01,"halted":0,"volume":276570,"hourTrading":{"tag":"盘前","latestPrice":5.0469,"preClose":5.13,"latestTime":"06:28 EDT","volume":4769,"amount":19222.12216,"timestamp":1789381735421,"change":-0.0831,"changeRate":-0.016199,"amplitude":0.198226},"delay":0,"changeRate":0.023952095808383256,"floatShares":11168300,"shares":21696893,"eps":-3.207951,"marketStatus":"Pre-Mkt","change":0.12,"latestTime":"09-14 06:30:04 EDT","open":5.11,"high":5.54,"low":4.975,"amount":1426131.82215,"amplitude":0.112774,"askPrice":5.55,"askSize":100,"bidPrice":4.07,"bidSize":49,"shortable":3,"etf":0,"ttmEps":-3.207951,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":5.13,"preHourTrading":{"tag":"盘前","latestPrice":5.0469,"preClose":5.13,"latestTime":"06:28 EDT","volume":4769,"amount":19222.12216,"timestamp":1789381735421,"change":-0.0831,"changeRate":-0.016199,"amplitude":0.198226},"postHourTrading":{"tag":"盘后","latestPrice":5.13,"preClose":5.13,"latestTime":"19:30 EDT","volume":206,"amount":1046.1438,"timestamp":1789169407266,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6636650076334776,"impliedVol":1.0917,"impliedVolPercentile":0.4037},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":11168300,"roa":"-40.38%","roe":"-66.02%","lyrEps":-0.74,"volumeRatio":1.6636650076334776,"shares":21696893,"dividePrice":0,"high":5.54,"amplitude":0.112774,"preClose":5.01,"low":4.975,"week52Low":3.35,"pbRate":"1.49","week52High":17.94,"institutionHeld":0,"latestPrice":5.13,"committee":-0.342282,"eps":-3.207951,"divideRate":0,"volume":276570,"delay":0,"ttmEps":-3.207951,"open":5.11,"prevYearClose":13.125,"prevWeekClose":5.13,"prevMonthClose":6.1,"prevQuarterClose":5.76,"fiveDayClose":5.73,"twentyDayClose":6.41,"sixtyDayClose":3.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"AARD","fiscalQuarterEnding":"2026/06","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-05-07","symbol":"AARD","fiscalQuarterEnding":"2026/03","expectedEps":-0.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2026-03-23","symbol":"AARD","fiscalQuarterEnding":"2025/12","expectedEps":-0.81,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-11-13","symbol":"AARD","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-08-13","symbol":"AARD","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2026-09-11","current":-1.599152,"percent":0.887755,"low":-51.17654,"twenty":-9.389042,"median":-6.017873,"eighty":-1.978384,"high":-1.08662,"avg":-7.626575,"sd":8.299905,"marketCap":109643078},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-17","current":-7.977371,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"marketCap":164238114},{"date":"2025-04-25","current":-8.66235,"twenty":-37.766803,"median":-27.946841,"eighty":-8.371497,"marketCap":178340462},{"date":"2025-05-02","current":-11.939711,"twenty":-36.900511,"median":-27.412825,"eighty":-8.371497,"marketCap":245814773},{"date":"2025-05-09","current":-11.307423,"twenty":-34.865316,"median":-26.68597,"eighty":-8.46634,"marketCap":232797221},{"date":"2025-05-16","current":-7.114571,"twenty":-32.693651,"median":-13.552046,"eighty":-8.46634,"marketCap":197215912},{"date":"2025-05-23","current":-7.834638,"twenty":-31.0204,"median":-11.823792,"eighty":-8.360959,"marketCap":217176159},{"date":"2025-05-30","current":-8.061615,"twenty":-30.818661,"median":-11.433881,"eighty":-8.172533,"marketCap":223467976},{"date":"2025-06-06","current":-9.353039,"twenty":-30.367714,"median":-11.107198,"eighty":-8.178795,"marketCap":259266244},{"date":"2025-06-13","current":-8.656453,"twenty":-30.076972,"median":-10.833207,"eighty":-8.210998,"marketCap":239956875},{"date":"2025-06-20","current":-9.454788,"twenty":-30.053238,"median":-10.188135,"eighty":-8.218152,"marketCap":262086713},{"date":"2025-06-27","current":-10.84796,"twenty":-29.697227,"median":-10.664596,"eighty":-8.356744,"marketCap":300705451},{"date":"2025-07-03","current":-10.894921,"twenty":-29.459887,"median":-10.613156,"eighty":-8.365174,"marketCap":302007206},{"date":"2025-07-11","current":-9.861782,"twenty":-29.308323,"median":-10.597502,"eighty":-8.375712,"marketCap":273368592},{"date":"2025-07-18","current":-9.360866,"twenty":-28.618005,"median":-10.433139,"eighty":-8.40036,"marketCap":259483203},{"date":"2025-07-25","current":-10.542714,"twenty":-28.285052,"median":-10.45662,"eighty":-8.474871,"marketCap":292244042},{"date":"2025-08-01","current":-9.4,"twenty":-28.006176,"median":-10.433139,"eighty":-8.577715,"marketCap":260567999},{"date":"2025-08-08","current":-9.368693,"twenty":-27.946841,"median":-10.061366,"eighty":-8.607418,"marketCap":259700162},{"date":"2025-08-15","current":-6.668132,"twenty":-27.567096,"median":-9.861782,"eighty":-8.474871,"marketCap":244307015},{"date":"2025-08-22","current":-5.762071,"twenty":-27.424692,"median":-9.803081,"eighty":-8.329026,"marketCap":211110768},{"date":"2025-08-29","current":-5.027748,"twenty":-27.270421,"median":-9.525229,"eighty":-8.145134,"marketCap":184206621},{"date":"2025-09-05","current":-5.027748,"twenty":-27.074615,"median":-9.478268,"eighty":-8.014507,"marketCap":184206621},{"date":"2025-09-12","current":-4.61321,"twenty":-26.629602,"median":-9.396086,"eighty":-7.797069,"marketCap":169018796},{"date":"2025-09-19","current":-6.685898,"twenty":-23.929853,"median":-9.368693,"eighty":-7.515801,"marketCap":244957921},{"date":"2025-09-26","current":-7.503129,"twenty":-17.043362,"median":-9.298251,"eighty":-7.308831,"marketCap":274899634},{"date":"2025-10-03","current":-9.102059,"twenty":-12.821851,"median":-9.210333,"eighty":-7.389343,"marketCap":333481245},{"date":"2025-10-10","current":-9.824539,"twenty":-12.161077,"median":-9.298251,"eighty":-7.460987,"marketCap":359951454},{"date":"2025-10-17","current":-7.876213,"twenty":-12.040618,"median":-9.212156,"eighty":-7.503145,"marketCap":288568676},{"date":"2025-10-24","current":-6.425331,"twenty":-11.978881,"median":-9.149542,"eighty":-7.334887,"marketCap":235411289},{"date":"2025-10-31","current":-6.194375,"twenty":-11.800608,"median":-9.102059,"eighty":-7.096882,"marketCap":226949500},{"date":"2025-11-07","current":-5.844979,"twenty":-11.619352,"median":-9.083015,"eighty":-6.739195,"marketCap":214148333},{"date":"2025-11-14","current":-6.453893,"twenty":-11.527382,"median":-8.978494,"eighty":-6.599437,"marketCap":236457733},{"date":"2025-11-21","current":-4.209833,"twenty":-11.386619,"median":-8.807467,"eighty":-6.451943,"marketCap":205321954},{"date":"2025-11-28","current":-4.455369,"twenty":-11.26527,"median":-8.719067,"eighty":-6.366112,"marketCap":217297254},{"date":"2025-12-05","current":-5.535729,"twenty":-11.176245,"median":-8.71121,"eighty":-6.20385,"marketCap":269988572},{"date":"2025-12-12","current":-6.968768,"twenty":-11.12541,"median":-8.663092,"eighty":-6.182531,"marketCap":339880775},{"date":"2025-12-19","current":-6.111623,"twenty":-11.06083,"median":-8.610671,"eighty":-6.174808,"marketCap":298076093},{"date":"2025-12-26","current":-6.366088,"twenty":-10.989171,"median":-8.599121,"eighty":-6.172233,"marketCap":310486858},{"date":"2026-01-02","current":-5.859391,"twenty":-10.980741,"median":-8.405995,"eighty":-6.111623,"marketCap":285774195},{"date":"2026-01-09","current":-6.477696,"twenty":-10.894921,"median":-8.362013,"eighty":-6.093766,"marketCap":315930176},{"date":"2026-01-16","current":-6.852697,"twenty":-10.894921,"median":-8.218152,"eighty":-6.111623,"marketCap":334219725},{"date":"2026-01-23","current":-6.732161,"twenty":-10.894921,"median":-8.171191,"eighty":-6.111623,"marketCap":328340941},{"date":"2026-01-30","current":-5.959837,"twenty":-10.857352,"median":-8.086731,"eighty":-6.108052,"marketCap":290673181},{"date":"2026-02-06","current":-5.040192,"twenty":-10.779084,"median":-8.030062,"eighty":-6.020346,"marketCap":245820240},{"date":"2026-02-13","current":-5.482157,"twenty":-10.700911,"median":-7.926792,"eighty":-5.956266,"marketCap":267375780},{"date":"2026-02-20","current":-5.540193,"twenty":-10.673027,"median":-7.864204,"eighty":-5.92323,"marketCap":270206305},{"date":"2026-02-27","current":-5.580372,"twenty":-10.643124,"median":-7.834638,"eighty":-5.890776,"marketCap":272165900},{"date":"2026-03-06","current":-2.562507,"twenty":-10.619417,"median":-7.684115,"eighty":-5.801764,"marketCap":124978581},{"date":"2026-03-13","current":-2.34822,"twenty":-10.594371,"median":-7.524231,"eighty":-5.747859,"marketCap":114527410},{"date":"2026-03-20","current":-2.187506,"twenty":-10.558368,"median":-7.450451,"eighty":-5.647336,"marketCap":106689032},{"date":"2026-03-27","current":-1.329623,"twenty":-10.505146,"median":-7.272172,"eighty":-5.612515,"marketCap":76574303},{"date":"2026-04-02","current":-1.549332,"twenty":-10.461316,"median":-7.114571,"eighty":-5.565193,"marketCap":89227607},{"date":"2026-04-10","current":-1.477359,"twenty":-10.383939,"median":-7.072594,"eighty":-5.510729,"marketCap":85082559},{"date":"2026-04-17","current":-1.890261,"twenty":-10.268548,"median":-6.92859,"eighty":-5.336927,"marketCap":108862044},{"date":"2026-04-24","current":-2.034209,"twenty":-10.187377,"median":-6.86609,"eighty":-5.089336,"marketCap":117152140},{"date":"2026-05-01","current":-2.056938,"twenty":-10.153251,"median":-6.792493,"eighty":-4.960237,"marketCap":118461102},{"date":"2026-05-08","current":-1.748556,"twenty":-10.125375,"median":-6.716536,"eighty":-4.705593,"marketCap":122169829},{"date":"2026-05-15","current":-2.101422,"twenty":-10.043581,"median":-6.685898,"eighty":-4.518505,"marketCap":146824271},{"date":"2026-05-22","current":-1.408234,"twenty":-9.951007,"median":-6.641483,"eighty":-4.307154,"marketCap":98391896},{"date":"2026-05-29","current":-1.311437,"twenty":-9.918135,"median":-6.60716,"eighty":-4.188404,"marketCap":91628817},{"date":"2026-06-05","current":-1.230253,"twenty":-9.857086,"median":-6.549693,"eighty":-2.633043,"marketCap":85956556},{"date":"2026-06-12","current":-1.136579,"twenty":-9.835549,"median":-6.495974,"eighty":-2.45715,"marketCap":79411641},{"date":"2026-06-18","current":-1.192783,"twenty":-9.824539,"median":-6.468768,"eighty":-2.34822,"marketCap":83338590},{"date":"2026-06-26","current":-1.57997,"twenty":-9.822648,"median":-6.449019,"eighty":-2.187506,"marketCap":110390908},{"date":"2026-07-02","current":-1.754828,"twenty":-9.791341,"median":-6.425331,"eighty":-2.13573,"marketCap":122608083},{"date":"2026-07-10","current":-1.561235,"twenty":-9.726041,"median":-6.368321,"eighty":-2.087243,"marketCap":109081925},{"date":"2026-07-17","current":-1.976523,"twenty":-9.645626,"median":-6.354268,"eighty":-2.066183,"marketCap":138097717},{"date":"2026-07-24","current":-1.995258,"twenty":-9.546006,"median":-6.285834,"eighty":-2.034209,"marketCap":139406700},{"date":"2026-07-31","current":-1.998381,"twenty":-9.523603,"median":-6.216183,"eighty":-2.015866,"marketCap":139624864},{"date":"2026-08-07","current":-2.279403,"twenty":-9.505361,"median":-6.182531,"eighty":-2.029869,"marketCap":159259610},{"date":"2026-08-14","current":-2.007209,"twenty":-9.48453,"median":-6.16129,"eighty":-2.029869,"marketCap":140281862},{"date":"2026-08-21","current":-1.844378,"twenty":-9.46418,"median":-6.116088,"eighty":-2.0169,"marketCap":128901742},{"date":"2026-08-28","current":-2.072968,"twenty":-9.421915,"median":-6.102695,"eighty":-2.029869,"marketCap":144877680},{"date":"2026-09-04","current":-1.794276,"twenty":-9.395304,"median":-6.053587,"eighty":-1.99756,"marketCap":125400167},{"date":"2026-09-11","current":-1.568817,"twenty":-9.389042,"median":-6.017873,"eighty":-1.978384,"marketCap":109643078}],"updateTime":1789374243018},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658451129","title":"Press Release: Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658451129","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658451129?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:53","pubTimestamp":1786481580,"startTime":"0","endTime":"0","summary":"and the OLE  trial to assess the totality of. available efficacy and safety data and to support an informed. determination of next steps for the ARD-101 program. In June 2026, the. Company terminated the HERO and the OLE trial and does not currently. intend to resume these trials as previously designed.-- In May 2026, the Company announced that the U.S. Food and Drug. Administration  placed a full clinical hold on its investigational. new drug application  for ARD-101, related to the Company's. previously announced voluntary pause. The clinical hold applies to all. previously ongoing clinical studies under the IND, including the Phase 3. HERO trial evaluating ARD-101 for the treatment of hyperphagia in. patients with Prader-Willi Syndrome  and the Phase 3 OLE trial.Second Quarter 2026 Financial Highlights-- Cash Position: As of June 30, 2026, Aardvark had cash, cash equivalents. and short-term investments of $73.9 million, compared to $91.2 million as. of March 31, 2026. Based on curre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","HYLG","MEDX","NVIB","IND","BK4007","GDOC","PWS","BMED","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641628","title":"Aardvark Therapeutics, Inc. Expected to Post a Loss of 87 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641628","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641628?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:55","pubTimestamp":1786110905,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics, Inc. <AARD.OQ> expected to post a loss of87cents a share - Earnings PreviewAardvark Therapeutics, Inc.AARD.OQAARD.Ois expected to  show no change in quarterly revenue when it re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652032290","title":"Aardvark Therapeutics Price Target Announced at $6.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2652032290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652032290?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:30","pubTimestamp":1784547000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings(END) Dow Jones NewswiresJuly 20, 2026 07:30 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647464304","title":"Aardvark Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647464304","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647464304?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:06","pubTimestamp":1782763610,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics announces annual shareholder meetingAardvark Therapeutics will hold its 2026 annual stockholders meeting virtually on Aug. 14, 2026.Shareholders will vote to elect two Class I di","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL9jTSR7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643775213","title":"Aardvark Therapeutics Implements Executive Retention Bonus Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2643775213","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643775213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:24","pubTimestamp":1781299461,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics, Inc. ( ($AARD) ) has shared an update. On June 10, 2026, Aardvark Therapeutics, Inc. entered into a retention bonus agreemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-implements-executive-retention-bonus-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-implements-executive-retention-bonus-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643773290","title":"Aardvark Therapeutics offers CFO Nelson Sun USD 346,500 retention bonus package","url":"https://stock-news.laohu8.com/highlight/detail?id=2643773290","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643773290?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:06","pubTimestamp":1781294807,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics entered retention bonus letter agreements on June 10, 2026 with CFO/COO Nelson Sun, CMO Manasi Jaiman.Sun: USD 346,500 cash bonus for 2026, including a guaranteed annual bonus of USD 198,000; payable Jan. 1, 2027.Jaiman: USD 357,000 cash bonus for 2026, including a guaranteed annual bonus of USD 204,000; payable Jan. 1, 2027.Both awards vest on continued employment through Jan. 1, 2027; full payment also due on termination without cause or good-reason resignation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL7VGYl4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636122019","title":"FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2636122019","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636122019?lang=en_us&edition=fundamental","pubTime":"2026-05-18 05:06","pubTimestamp":1779051987,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics, Inc., the Healthcare sector company, was revisited by a Wall Street analyst on May 15. Analyst Tazeen Ahmad from Bank of Ame...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/fda-clinical-hold-competitive-pressure-drive-aardvark-therapeutics-downgrade-as-price-target-slashed-from-18-to-4-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/fda-clinical-hold-competitive-pressure-drive-aardvark-therapeutics-downgrade-as-price-target-slashed-from-18-to-4-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635379037","title":"Aardvark Therapeutics downgraded to Underperform from Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2635379037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635379037?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:00","pubTimestamp":1778875216,"startTime":"0","endTime":"0","summary":"BofA analyst Tazeen Ahmad downgraded Aardvark Therapeutics (AARD) to Underperform from Buy with a price target of $4, down from $18, following the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-underperform-from-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-underperform-from-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635343880","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2635343880","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635343880?lang=en_us&edition=fundamental","pubTime":"2026-05-16 02:20","pubTimestamp":1778869228,"startTime":"0","endTime":"0","summary":"LanzaTech Global  signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.Aardvark Therapeutics  said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.York Space Systems  reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YSS","LNZA","BK4007","BK4120","AARD","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635003161","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2635003161","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635003161?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:33","pubTimestamp":1778866395,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index falling 0.9% and the State Street Healthcare Select Sector SPDR ETF  shedding 0.8%.The iShares Biotechnology ETF  dropped 2.5%.In corporate news, Aardvark Therapeutics  shares fell 31% after the firm said the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101. Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1668664300.SGD","LU2347655156.SGD","IE00BKVL7J92.USD","LU1720051017.SGD","LU1988902786.USD","LU0006306889.USD","LU1548497426.USD","LU0158827781.USD","LU0029874061.USD","LU1363072403.SGD","BK4504","BK4516","LU0106831901.USD","BK4137","HCSG","BK4581","BK4007","LU0557290698.USD","LU2089283258.USD","LU1791710400.SGD","LU1989772840.SGD","LU0795875086.SGD","BK4127","LU2023251221.USD","LU1732799900.SGD","LU0128526141.USD","AARD","LU0320765646.SGD","LU0882574139.USD","LU0314104364.USD","LU2089284900.SGD","BK4585","LU2271345857.HKD","LU0225283273.USD","IBB","XLV","LU2133065610.SGD","LU1244550577.SGD","LU0795875169.SGD","LU1989772923.USD","LU1720051108.HKD","LU0528227936.USD","LU1732800096.USD","LU1244550221.USD","LU0267386448.USD","LU1064131342.USD","LU2028103732.USD","XBI","LABU","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035803","title":"Aardvark Therapeutics Cut to Neutral From Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035803?lang=en_us&edition=fundamental","pubTime":"2026-05-15 22:52","pubTimestamp":1778856720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 10:52 ET (14:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635499033","title":"Aardvark Therapeutics Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635499033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635499033?lang=en_us&edition=fundamental","pubTime":"2026-05-15 22:36","pubTimestamp":1778855816,"startTime":"0","endTime":"0","summary":"09:41 EDT Aardvark Therapeutics (AARD) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-inc-trading-resumes-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-inc-trading-resumes-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635809830","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2635809830","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635809830?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:36","pubTimestamp":1778852190,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nAQN2LZ6ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635808010","title":"Aardvark Therapeutics downgraded to Neutral from Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635808010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635808010?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:30","pubTimestamp":1778851850,"startTime":"0","endTime":"0","summary":"BTIG downgraded Aardvark Therapeutics (AARD) to Neutral from Buy with no price target after the FDA placed a full clinical hold on ARD-101. While m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087277","title":"Aardvark Therapeutics Could Regain Investor Interest With Upcoming Results -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087277","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087277?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:18","pubTimestamp":1778851080,"startTime":"0","endTime":"0","summary":"1318 GMT - Oppenheimer analysts say investors could show interest in Aardvark Therapeutics again if upcoming results for ARD-101, a treatment for people with the genetic disorder Prader-Willi Syndrome, show unequivocal efficacy. The analysts expect the company to unblind Phase 3 trial results in July after its application for the treatment was placed on clinical hold by the Food and Drug Administration. The trial's volume of placebo-controlled efficacy data could be sufficient to show whether its worthwhile to push ARD-101 forward, they say. \"We can envision a scenario in which a dose level capable of yielding disease benefit remains below that associated with the observed cardiac safety signal,\" the analysts say. \"While the implications of this safety signal to ARD-101's forward development remain unclear, we believe an unequivocal efficacy showing would be positively received by the market.\"","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635090084","title":"Aardvark Therapeutics Inc : Btig Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635090084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635090084?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:33","pubTimestamp":1778848414,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635608324","title":"Morgan Stanley Downgrades Aardvark Therapeutics to Underweight From Equalweight, Cuts Price Target to $3 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2635608324","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635608324?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:28","pubTimestamp":1778840929,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) has an average rating of overweight and mean price target of $18.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722135","title":"Stocks to Watch: Figma, Aardvark, Gambling.com, P3 Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722135?lang=en_us&edition=fundamental","pubTime":"2026-05-15 07:22","pubTimestamp":1778800920,"startTime":"0","endTime":"0","summary":"Figma raised its outlook, citing more customers for its AI products. Shares rose 12% to $22.69 in after-hours trading Thursday.Aardvark Therapeutics said the Food and Drug Administration put its drug on a clinical hold. The stock slid 18% to $5.52 after the bell.Gambling.com said it was cutting its guidance and reducing its workforce by 25%. Shares sank 29% to $2.96.P3 Health Partners raised its earnings outlook. The stock gained 46% to $5.90.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4007","FIG","BK4023","GAMB","FIGG","BK4009","AARD","BK4539","PIII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635724673","title":"Aardvark Therapeutics announces FDA clinical hold on ARD-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2635724673","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635724673?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:08","pubTimestamp":1778796513,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) announced that the U.S. Food and Drug Administration has placed a full clinical hold on its investigational new drug a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-announces-fda-clinical-hold-on-ard-101-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-announces-fda-clinical-hold-on-ard-101-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AARD","ARD","LABU","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635117729","title":"Aardvark Therapeutics Says FDA Placed Hold on ARD-101 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2635117729","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635117729?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:08","pubTimestamp":1778792880,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics' drug application for ARD-101, a treatment for people with the genetic disorder Prader-Willi Syndrome, was placed on clinical hold by the Food and Drug Administration.The clinical-stage biopharmaceutical company said after the close Thursday the hold applies to all ongoing clinical studies under the application, including two Phase 3 trials.Shares slid 14% to $5.82 in post-market trading.The hold was related to Aardvark's voluntary pause of one of the Phase 3 trials in February, which it said at the time was due to safety issues in the study.Aardvark is in talks with the FDA to resolve the hold and determine a path forward for ARD-101, it said. The company also plans to unblind the clinical data from both trials to assess efficacy and safety, which it said will help decide next steps for the program.ARD-101 is designed to suppress hunger for the treatment of Prader-Willi Syndrome and metabolic diseases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","ARD","AARD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":77,"code":"91000000","status":"200"}]}}